Effects of a Five-Dimensional Intervention Program Based on Inner Strength on Demoralization Syndrome in Elderly Cancer Patients
1 other identifier
interventional
66
1 country
1
Brief Summary
From January 2025 to January 2026, a total of 66 elderly cancer patients with demoralization syndrome who were hospitalized in the Department of Internal Medicine at Peking Union Medical College Hospital were enrolled. Participants were allocated randomly to either a control group (CG, n = 33) or an intervention group (IG, n = 33) utilizing a random number table in combination with the ward-floor allocation method. The CG received routine oncology nursing care, whereas the IG received a one-month, five-dimensional intervention program based on inner strength in addition to standard care. Outcomes were assessed utilizing the Chinese versions of Demoralization Scale, Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS), Inner Strength Scale, and Self-Efficacy Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2025
CompletedFirst Submitted
Initial submission to the registry
May 7, 2026
CompletedFirst Posted
Study publicly available on registry
June 4, 2026
CompletedJune 4, 2026
April 1, 2026
5 months
May 7, 2026
May 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Chinese version of the Disappointment Scale
one month
Secondary Outcomes (4)
self-rating anxiety scale
one month
Depression Self-Rating Scale
one month
Chinese Version of the Inner Strength Scale
one month
Self-Efficacy Scale
one month
Study Arms (1)
Inner strength; Elderly; Cancer; Demoralization syndrome
OTHERpsychological support
Interventions
From January 2025 to January 2026, a total of 66 elderly cancer patients with demoralization syndrome who were hospitalized in the Department of Internal Medicine at our hospital were enrolled. Participants were allocated randomly to either a control group (CG, n = 33) or an intervention group (IG, n = 33) utilizing a random number table in combination with the ward-floor allocation method. The CG received routine oncology nursing care, whereas the IG received a one-month, five-dimensional intervention program based on inner strength in addition to standard care. Outcomes were assessed utilizing the Chinese versions of Demoralization Scale, Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS), Inner Strength Scale, and Self-Efficacy Scale.
Eligibility Criteria
You may qualify if:
- Age ≥ 60 years
- Diagnosis of a malignant tumor confirmed by pathological biopsy or imaging, in accordance with the Diagnosis and Treatment Specifications for Malignant Tumors
- Fulfillment of the diagnostic criteria for demoralization syndrome, described as a score \> 30 on the Chinese version of the Demoralization Scale (DS)
- Clear consciousness, with the capability to communicate effectively or complete questionnaires, and no evidence of cognitive impairment
- Voluntary participation with signed informed consent
- Expected survival ≥ 3 months, without vital organs' severe dysfunction, including the liver, kidneys, or heart
You may not qualify if:
- Presence of psychiatric disorders, severe cognitive impairment, aphasia, or other conditions that would interfere with participation in the intervention or assessments
- Severe complications, cachexia, or rapidly progressing disease
- Receipt of psychological interventions or psychotropic medications within the previous month
- Transfer to another hospital, withdrawal from the study, or loss to follow-up during the study period
- A history of alcohol or drug dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, 100076, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2026
First Posted
June 4, 2026
Study Start
July 4, 2025
Primary Completion
December 12, 2025
Study Completion
December 12, 2025
Last Updated
June 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share